Brics and straws

Brics and straws

Brics Bank has its own limitations, and let us hope it will...
Much ado about execution

Much ado about execution

Effective delivery must be brought to the centre of policy-making...

GlaxoSmithKline India stake @$940 mn

Nov 26 2012, 19:32 IST
Comments 0
GlaxoSmithKline Consumer Healthcare shares surge following news that its UK-based parent group plans to raise its stake in the unit. GlaxoSmithKline Consumer Healthcare shares surge following news that its UK-based parent group plans to raise its stake in the unit.
SummaryGSK plans to raise stake in Indian arm by up to 31.8 per cent for for Rs 5,220 cr.

has offered to hike stake in its Indian subsidiary, GlaxoSmithKline Consumer Healthcare, to up to 75 per cent which would entail an outgo of over Rs 5,220 crore.

"GlaxoSmithKline (GSK) has announced a voluntary open offer to increase its stake in its publicly-listed consumer healthcare subsidiary in India (GlaxoSmithKline Consumer Healthcare), from 43.2 per cent to up to 75 per cent at a price of Rs 3,900 per share," the company said in a statement.

The offer made pursuant to the rules of the Securities and Exchange Board of India, is to acquire up to 13,389,410 shares, representing 31.8 per cent of the total outstanding shares of the Indian company, it added.

The potential total value of the transaction at the offer price is approximately Rs 5,220 crore or 591 million pounds, the company said.

The offer represents a premium of about 28 per cent to GlaxoSmithKline Consumer Healthcare's closing share price on the National Stock Exchange on November 23, 2012, GlaxoSmithKline said.

Commenting on the development, GSK Chief Strategy Officer David Redfern said: "This transaction represents a further step in GSK's strategy to invest in the world's fastest growing markets and, we believe, it offers a liquidity opportunity at an attractive premium for existing shareholders".

The transaction, which will be funded through GSK's existing cash resources, will be earnings neutral for the first year and accretive thereafter and will not impact expectations for the group's long-term share buyback programme, GSK said.

Subject to regulatory clearance, the offer period is expected to begin in January 2013. Payment for the shares will take place shortly after close of the offer, it added.

As on quarter ended September 2012, the foreign promoter of GSKCH held 43.2 per cent stake in the company while the public shareholding is at 56.84 per cent.

Securities regulations in India require a minimum public shareholding of 25 per cent for a company to maintain a public listing in the country.

GSK's Consumer Healthcare business in India generated over Rs 2,800 crore turnover in the financial year ended 31 December, 2011. The company employs nearly 3,200 people.

GSK shares surge 20 pc as UK-based parent makes open offer

(PTI) Shares of GlaxoSmithKline Consumer Healthcare today skyrocketed by 20 per cent to touch the upper circuit limit after its UK-based parent GlaxoSmithKline announced an open offer to hike stake in the subsidiary.

Shares of GlaxoSmithKline Consumer Healthcare zoomed up by 20 per cent to touch the upper circuit limit of Rs

Single Page Format
Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...